These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3069432

  • 1. [The pharmacokinetic and toxicologic profile of 8-methoxypsoralen. The basis for safe and effective PUVA therapy].
    Schmid J, Brickl R, Koss FW.
    Derm Beruf Umwelt; 1988; 36(6):177-85. PubMed ID: 3069432
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A, Hofer A, Legat F, Kerl H, Wolf P.
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [Abstract] [Full Text] [Related]

  • 3. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F, Schmuth M, Sepp N, Fritsch P.
    Acta Derm Venereol; 2005 Mar; 85(4):329-32. PubMed ID: 16191854
    [Abstract] [Full Text] [Related]

  • 4. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
    Beani JC, Bonnot D, Berthod F, Boitard M, Reymond JL, Beriel H, Amblard P.
    Ann Dermatol Venereol; 1991 Mar; 118(4):273-5. PubMed ID: 2069337
    [Abstract] [Full Text] [Related]

  • 5. Liver biopsy in PUVA-treated patients.
    Zachariae H, Kragballe K, Søgaard H.
    Acta Derm Venereol; 1979 Mar; 59(3):268-70. PubMed ID: 87091
    [Abstract] [Full Text] [Related]

  • 6. British Photodermatology Group guidelines for PUVA.
    Br J Dermatol; 1994 Feb; 130(2):246-55. PubMed ID: 8123580
    [No Abstract] [Full Text] [Related]

  • 7. [8-methoxypsoralen serum content of problem patients in PUVA therapy].
    Walther T, Haustein UF.
    Dermatol Monatsschr; 1990 Feb; 176(5-6):317-21. PubMed ID: 2227049
    [Abstract] [Full Text] [Related]

  • 8. [The risks of photochemotherapy (author's transl)].
    Stüttgen G, Kentsch V, Schalla W, Schneider L.
    Z Hautkr; 1981 Nov 01; 56(21):1379-99. PubMed ID: 6458954
    [Abstract] [Full Text] [Related]

  • 9. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
    Akita Y, Watanabe D, Yanagishita T, Kuhara T, Kawamura C, Masuda Y, Kawada M, Nakaseko H, Tamada Y, Matsumoto Y.
    Photodermatol Photoimmunol Photomed; 2007 Nov 01; 23(2-3):95-7. PubMed ID: 17523931
    [Abstract] [Full Text] [Related]

  • 10. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
    Nørgaard M, Hueg B, Staberg B.
    Photodermatol; 1985 Aug 01; 2(4):252-6. PubMed ID: 3903679
    [Abstract] [Full Text] [Related]

  • 11. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters.
    Marrakchi S, Decloquement L, Pollet P, Briand G, Loesche C, Bocquet JL, Degand P, Thomas P.
    Photodermatol Photoimmunol Photomed; 1991 Oct 01; 8(5):206-11. PubMed ID: 1822684
    [Abstract] [Full Text] [Related]

  • 12. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
    Staberg B, Hueg B.
    Acta Derm Venereol; 1985 Oct 01; 65(6):553-5. PubMed ID: 2420126
    [Abstract] [Full Text] [Related]

  • 13. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE, Panizzon RG.
    Dermatology; 1999 Oct 01; 199(2):106-12. PubMed ID: 10559574
    [Abstract] [Full Text] [Related]

  • 14. Minimal phototoxic dose determination at 72 h vs. 120 h.
    González-Sixto B, Rosón E, Mayo E, García-Doval I, Conde A, Cruces M.
    J Eur Acad Dermatol Venereol; 2007 Nov 01; 21(10):1419-20. PubMed ID: 17958855
    [No Abstract] [Full Text] [Related]

  • 15. [Photochemotherapy by the PUVA method in dermatology].
    Azizi E, Juzuk S, Schewach-Millett M, Kushelevsky A.
    Harefuah; 1983 Dec 01; 105(11):351-3. PubMed ID: 6671573
    [No Abstract] [Full Text] [Related]

  • 16. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D, Béani JC, Boitard M, Reymond JL, Bériel H, Amblard P.
    Photodermatol Photoimmunol Photomed; 1994 Feb 01; 10(1):33-7. PubMed ID: 8180098
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
    Steinmeyer K, Grundmann-Kollmann M, Podda M, Kaufmann R.
    Hautarzt; 2001 Oct 01; 52(10):885-7. PubMed ID: 17690819
    [Abstract] [Full Text] [Related]

  • 18. Photochemotherapy in psoriasis and other skin diseases.
    Adrian RM.
    Am Fam Physician; 1981 May 01; 23(5):95-100. PubMed ID: 7234635
    [Abstract] [Full Text] [Related]

  • 19. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).
    Bond CA, Grant K, Boh L.
    Am J Hosp Pharm; 1981 Jul 01; 38(7):990-5. PubMed ID: 7020414
    [Abstract] [Full Text] [Related]

  • 20. Photochemotherapy of psoriasis (PUVA) without specialized equipment.
    Petrozzi JW, Kligman AM.
    Arch Dermatol; 1978 Mar 01; 114(3):387-90. PubMed ID: 629574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.